The has announced a three-year, $5.5 million grant from the to support the development of new cancer treatments and vaccines at its .
The grant will enable university researchers to move plant-derived vaccines for cervical and colon cancer into clinical trials and further develop drug-delivery systems to allow for higher concentrations of anti-cancer drugs to be transported directly to human tumors and increase a tumor’s sensitivity to treatment. The plants involved in the research include tobacco, soybeans, and berries. To date, the trust has awarded nearly $15 million to the university for cancer research.
"Federal funding for research continues to be more and more competitive, with fewer researchers receiving funds each year," said University of Louisville executive vice president for health affairs David L. Dunn. "The resources the Helmsley Charitable Trust provide enable our internationally renowned researchers to continue with their groundbreaking work that has the potential to transform the lives of people worldwide. It is through these significant partnerships that innovative healthcare approaches are possible."